Grozier, L. (1973), 'The third revolution in psychiatry: fluphenazine decanoate. In F. J. Ayd (ed.), The Future of Pharmacotherapy: Drug Dehvery Systems ( Baltimore : International Drug Therapy Newsletter), 97.
2.
Deniker, P. (1990), 'The neuroleptics: a historical survey'. Acta Psychiatrica Scandinavica, lxxxii (supplement 358), 83-87.
3.
Sakel, M. (1937), 'The origin and nature of the hypoglycemic therapy of the psychoses'. The Journal of Nervous and Mental Disease , lxxxv, 561-564.
4.
Bourne, H. (1953), 'The insulin myth'. Lancet, ii, 964-968.
5.
Ackner B., Harris, A. and Oldham, A.J. (1957), 'Insulin treatment of schizophrenia: a controlled study'. Lancet, ii, 607-611.
6.
Christie, I.A. (1970), Myth and Reality (London: Macmillan), 27.
7.
Popper, K. (1974), Unended Quest (Glasgow: Collins), 121.
8.
Gibbon, E. (1910), The Decline and Fall of the Roman Empire, Vol. I (London: Dent), 7.
9.
Cramond, W.A. (1987), 'Lessons from the insulin story in psychiatry'. Australian and New Zealand Journal of Psychiatry, xxi, 320-326.
10.
Lewis, A. (1945), 'On the place of physical treatment in psychiatry '. Brit. Med. Bull., iii, 22-24.
11.
Sargant, W. and Slater, E.T.O. (1944), An Introduction to Physical Methods of Treatment in Psychiatry (lst edition) ( Edinburgh: Livingstone), 1.
12.
Sakel, M. (1959), Address at the University of Vienna. In M. Rinkel and H. E. Himwich (eds), Insulin Treatment in Psychiatry ( New York: Philosophical Library), 375-380.
13.
Cameron, D.E. (1959), Introduction. In M. Rinkel and H. E. Himwich (eds), Insulin Treatment in Psychiatry ( New York: Philosophical Library), xxiii-xxvi.
14.
Sargant, W. and Slater, E.T.O. (1944), An Introduction to Physical Methods of Treatment in Psychiatry (lst edition) ( Edinburgh: Livingstone), 280.
15.
Collins, A. (1988), In the Sleep Room (Toronto : Lester Orpen Dennys).
16.
Shepherd, M. (1972), 'The classification of psychotropic drugs'. Psychol. Med., ii, 96-110.
17.
Snyder, S.H. (1990), 'The Dopamine Connection '. Nature, 347, 121-122.
18.
Collard, J. (1974), 'The main clinical classifications of neuroleptics'. Acta Psychiatrica Belgica, lxxiv, 462-469.
19.
Mayer-Gross, W. (1959), 'Model psychoses: their history, relevancy and limitations'. American Journal of Psychiatry , cxv, 673-682.
20.
Lewis, A. (1959), 'The impact of psychotropic drugs on the structure, function and future of psychiatric services'. In P. B. Bradley, P. Deniker and C. Radouco-Thomas (eds), Neuropsychopharmacology , Vol. 1, (Amsterdam: Elsevier), 207-212.
21.
Shepherd, M. and Watt, D.C. (1956), 'Chlorpromazine and reserpine in chronic schizophrenia: a controlled study'. Journal of Neurology, Neurosurgery and Psychiatry, xix, 232-236.
22.
Shepherd, M. (1958), 'The social outcome of early schizophrenia'. Psychiatria et Neurologia, cxxxvii, 224-229.
23.
Shepherd, M. , Goodman, N. and Watt, D.C. (1961), 'The application of hospital statistics in the evaluation of pharmacotherapy in a psychiatric population'. Comprehensive Psychiatry, ii, 11-19.
24.
Ødegaard, Ø. , (1964), 'Pattern of discharge from Norwegian psychiatric hospitals before and after the introduction of the psychotropic drugs'. American Journal of Psychiatry, cxx, 772-778.
25.
Shepherd, M. , Lader, M. and Rodnight, R. (1968), Clinical Psychopharmacology ( London: English Universities Press), 2-3.
